Cheniere Energy : 10-Q Filing Q1 2023
$0.370 / $ ... | May 2, 2023
Source: marketscreener.com
📰 Interactive Data File News
Page 9 - Interactive Data File News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interactive Data File. Real-time updates on events, politics, business and more.
Williams Industrial Services : 10-K/A Filing FY 2022
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment... | May 1, 2023
Source: marketscreener.com
Molecular Templates : 10-K/A Filing FY 2022
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ... | April 28, 2023
Source: marketscreener.com
VISTA GOLD CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure (form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On April 27, 2023, the Board of Directors... | April 28, 2023
Source: marketscreener.com
Antero Midstream : 10-Q | MarketScreener
<_ix3a_header><_ix3a_hidden><_ix3a_nonfraction unitref="Unit_Standard_USD_gdSwK0Ed3UWfJ1rH_-5nAg" _xs3a_nil="true"... | April 26, 2023
Source: marketscreener.com
AMERIPRISE FINANCIAL INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
Item 2.02 Results of Operations and Financial Condition. Ameriprise Financial, Inc. furnishes herewith, on Exhibit 99.1, a press release issued April 24, 2023, announcing its financial results for... | April 24, 2023
Ameriprise Financial Inc Interactive Data File Business Reporting Language Edgar Online Ameriprise Financial Nc Stock Exchange
Source: marketscreener.com
United Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 21, 2023
State Of Delaware United States Silver Spring Paula Mahon Securities Exchange Bylaws Of United Therapeutics Corporation
Source: marketscreener.com
MOLECULIN BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Item 7.01 Regulation FD Disclosure On April 18, 2023, Moleculin Biotech, Inc. , issued a press release which announced that positive preclinical data regarding the Companys next-generation... | April 18, 2023
United States Orange County Convention Center Moleculin Biotech Inc American Association For Cancer Research Securities Exchange Cancer Research
Source: marketscreener.com
SCWorx : Annual report pursuant to Section 13 and 15(d)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ANNUAL... | April 17, 2023
Source: marketscreener.com
Tandem Diabetes Care : 2022 Tandem Diabetes Care Annual Report
2022 Annual Report Maximus diagnosed 2018 7:35 AM ... | April 13, 2023
United States Commission File Number Securities Exchange Name Of Each Exchange On Which Tandem Diabetes Care Inc Exchange Commission
Source: marketscreener.com